High-Throughput Proteomic Biomarker Testing (CNS Panel 220 Argo NULISA Platform)

The contract requires the performance of high-throughput proteomic analysis on government-furnished biospecimens using the CNS Panel 220 Argo NULISA platform, with an annual capacity of up to 8,970 samples. The work demands rigorous quality control protocols and comprehensive batch bridging procedures to ensure data consistency and reliability across multiple runs and time periods. The analysis is focused on identifying and validating proteomic biomarkers relevant to central nervous system conditions, with all samples provided by the government and processed under strict regulatory and technical standards. The contract is classified as a subcontract under NAICS code 541380 and is managed by the National Institutes of Health under the Department of Health and Human Services. Performance is specifically required at the facility in Bethesda, Maryland, with a zip code of 20892. The solicitation was posted on May 7, 2026, and responses are due by May 13, 2026, at 3:00 PM Eastern Time. No set-aside designation is specified, and the point of contact information is not provided, though all work must comply with federal requirements for laboratory testing, sample handling, data integrity, and reporting.